Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: A comparative study of 73 patients

Lupus

Volumn 13, Issue 1, 2004, Pages 11-16

  Medina, G ^a   Vera Lastra, O ^b   Barile, L ^b   Salas, M ^c   Jara, Luis J ^b  

^a Hospital General de Zona No 76   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c CARO RESEARCH INSTITUTE   (United States)

Author keywords

Antiphospholipid syndrome; Damage index; Functional outcome; Males; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTHROPATHY; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DISEASE DURATION; FUNCTIONAL ASSESSMENT; HEART INFARCTION; HUMAN; LABORATORY DIAGNOSIS; LUNG EMBOLISM; LUPUS DAMAGE INDEX; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MESENTERIC ARTERY THROMBOSIS; MORTALITY; ORGAN INJURY; PRIORITY JOURNAL; SCORING SYSTEM; SKIN LUPUS ERYTHEMATOSUS; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; VEIN THROMBOSIS;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; HUMANS; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PULMONARY EMBOLISM;

EID: 1642460101     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu482oa     Document Type: Article

References (45)

1. Hughes GRV. Systemic lupus erythematosus. Postgrad Med J 1988; 64: 515-521.
2. Bell D, Rigsby R, Stiller C, Clark W, Harth M, Ebers G. HLA antigens in systemic lupus erythematosus: Relationship to disease, severity, age at onset, and sex. J Rheumatol 1984; 11: 475-479.
3. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT et al. Systemic lupus erythematosus. A review of clinic-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine 1985; 64: 285-295.
4. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine 1993; 72: 113-124.
5. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Alterations of estrogen metabolism in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1195-1198.
6. Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 713-736.
7. Jara LJ, Gómez-Sánchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus (SLE): Association with disease activity. Am J Med Sci 1992; 303: 222-226.
8. Kaufman LD, Gómez-Reino JJ, Heinicke MH, Gorevic PD. Male lupus: Retrospective analysis of the clinical and laboratory features of 52 patients with a review of the literature. Semin Arthritis Rheum 1989; 18: 189-197.
9. Miller MIT, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine 1983; 62: 327-334.
10. Sthoeger ZM, Geltner D, Rider A, Bentwitch Z. Systemic lupus erythematosus in 49 Israeli males: A retrospective study. Chin Exp Rheumatol 1987; 5: 233-240.
11. Molina JF, Drenkard C, Molina J, Cardiel MH, Uribe O, Anaya JM et al. Systemic lupus erythematosus in males. A study of 107 Latin-American patients. Medicine 1996; 75: 124-130.
12. Massardo L, Martinez ME, Jacobelli S, Villarroel L, Rosenberg H, Rivero S. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum 1994; 24: 1-11.
13. Lahita RG, Chiorazzi N, Gibofsky A, Winchester RJ, Kunkel HG. Familial systemic lupus erythematosus in males. Arthritis Rheum 1983; 26: 39-44.
14. Ward MM, Studenski S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990; 17: 220-224.
15. Wallace DJ. The clinical presentation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois' Lupus Erythematosus, 5th ed. William&Wilkins: Baltimore, 1997, 627-633.
16. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983; 287: 1088-1089.
17. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
18. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta-2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
19. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF. Lupus anticoagulant IgG are not directed to phospholipid only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
20. Alarcón-Segovia D, Sánchez Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
21. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero J et al. The 'Primary' antiphospholipid syndrome: Major clinical and serological features. Medicine 1989; 68: 366-374.
22. Mujic F, Cuadrado MJ, Lloyd M, Khamashta MA, Page G, Hughes GRV. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995; 22: 1589-1592.
23. Derksen RHWM, Gmeling-Meijling FHJ, De Groot PhG. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 1996; 5: 77-80.
24. Blanco F, Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J, Ingelmo M. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature. Rev Clin Esp 1999; 199: 586-588.
25. Austin HA 3rd, Muenz LR, Joyce KM, Antonovich TA, Kullick ME, Klippel JH et al. Prognostic factors in lupus nephritis: contributions of renal histologic data. Ant J Med 1983; 75: 382-391.
26. Blum A, Rubinow A, Galun E. Predominance of renal involvement in male patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991; 9: 206-207.
27. Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic PD. Male lupus: Retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature. Semin Arthritis Rheum 1989; 18: 189-197.
28. Chang D-M, Chang C-C, Koo S-Y, Chu S-J, Chang M-L. The clinical features and prognosis of male lupus in Taiwan. Lupus 1998; 7: 462-468.
29. Aydintug AO, Domenech I, Cervera R, Khamashta MA, Jedryka-Goral A, Vianna JL et al. Systemic lupus erythematosus in males: Analysis of clinical and laboratory features. Lupus 1992; 1: 295-298.
30. May KP, West SG, Moulds J et al. Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 528-533.
31. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-1311.
32. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
33. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M et al. The development and initial validation of the systemic lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
34. Gladman D, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C et al. The reliability of the systemic lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 809-813.
35. Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol 2000; 27: 2817-2821.
36. Harris EN, Pierangeli SS, Birch D. Anticardiolipin wet workshop report: 5th International Symposium on Antiphopholipid Antibodies. Am J Clin Pathol 1994; 101: 616-624.
37. Weber M, Hayem G, De Bandt M, Seifert B, Palazzo E, Roux S et al. Classification of an intermediate group of patients with antiphospholipid syndrome and lupus-like disease: primary or secondary antiphospholipid syndrome? J Rheumatol 1999; 26: 2131-2136.
38. Amigo MC, García-Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-1185.
39. Sokunbi DO, Miller F, Wadhwa NK, Nord EP. Reversible renal failure in the primary antiphospholipid syndrome - a report of two cases. J Am Soc Nephrol 1993; 4: 28-35.
40. Sakaguchi S, Kitasawa K, Watanabe M, Mukai K, Totsuka D, Shibata T et al. A case of primary antiphospholipid antibody syndrome with acute renal failure showing thrombotic microangiopathy. Am J Nephrol 1999; 19: 594-598.
41. Fakhouri F, Noel LH, Zuber J, Beafulis H, Martinez F, Lebon P et al. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 2003; 41: 1205-1211.
42. Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome. Br J Haematol 1996; 93: 1-5.
43. Galindo M, Khamashta MA, Hughes GRV. Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome. Rheumatology (Oxford) 1999; 38: 848-853.
44. Zonana-Nacach A, Camargo-Coronel A, Yanez P, de Lourdes-Sanchez M, Jimenez-Balderas FJ, Aceves-Avila J et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998; 7: 119-123.
45. Asherson RA, Cervera R, Piette JC, Font J, Lie JT, Burcoglu A et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine 1998; 77: 195-207.